The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, predicts Roots Analysis
A steadily increasing demand for participants in clinical research
studies, coupled to the complexities associated with patient enrolment, have
prompted drug / therapy developers to outsource this process to specialty
service providers
Roots Analysis is pleased to announce the publication of its
recent study, titled, “Patient
Recruitment and Retention Services
Marker, 2019-2030.”
The report offers a comprehensive study of the current scenario and
future potential of the players providing patient enrollment and retention
services. The study features an in-depth analysis, highlighting the
capabilities of the various stakeholders in this domain. In addition to other
elements, the study includes:
§ A
detailed assessment of the current market landscape of companies offering
patient recruitment and retention services.
§ An
analysis of the most active regions (in terms of patient recruitment
activity) engaged in this domain, featuring schematic world map
representations that highlight key hubs across the globe.
§ An
insightful 2X2 representation of the results of a competitiveness analysis of
various service providers highlighting capable players in this domain, based on
their respective capabilities.
§ Comprehensive
profiles of patient recruitment and retention service providers (shortlisted
on the basis of the number of services).
§ An
analysis of the partnerships that have been established in this domain, in the
recent past
§ A
review of emerging trends in the industry to overcome the challenges associated
with patient recruitment and retention
§ A detailed market forecast, featuring analysis of the current and
projected future opportunity across key market segments (listed below)
For Sample Report - https://www.rootsanalysis.com/reports/245/request-sample.html
§ Therapeutic
Area
§ Oncology
§ Infectious
Diseases
§ Cardiovascular
Diseases
§ CNS
Disorders
§ Respiratory
Disorders
§ Metabolic
Disorders
§ Others
§ Steps
in Patient Recruitment Process
§ Pre-screening
§ Screening
§ Phase
of Development
§ Phase
I
§ Phase
II
§ Phase
III
§ Phase
IV
§ Key
Geographical Region
§ North
America
§ Europe
§ Asia-Pacific
§ Rest
of the world
Transcripts
of interviews held with the following senior level representatives of
stakeholder companies
§ Simon
Klaasen, Co-founder and Managing Director, Link2Trials
§ Hagit
Nof, Chief Operation Officer and Business Development Officer, nRollmed
§ Paul
Ivsin, Managing Director, Seeker Health
Key
companies covered in the report
§ Acurian
§ BBK
Worldwide
§ Bright
Pharmaceuticals Services
§ ClinEdge
§ CSSi
§ CTM
§ FIDELIS
RESEARCH
§ Ignite
Data
§ Integrated
Clinical Trial Services
§ MMG
§ Pacific
Groove
§ Polaris
BioPharma Consulting
§ Topstone
Research
§ TrialWire
§ Tudor
Reilly Health
§ WCCT
Global
For
more information, please click on the following link:
About Roots Analysis
Roots Analysis is one of the fastest
growing market research companies, sharing fresh and independent perspectives
in the bio-pharmaceutical industry. The in-depth research, analysis and
insights are driven by an experienced leadership team which has gained many
years of significant experience in this sector. If you’d like help with your
growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private
Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Comments
Post a Comment